This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
News & Press: General News

Brian K. Nunnally and Cari Sänger-van de Griend Re-elected and Patrick Swann Elected to CASSS Board

Saturday, January 25, 2020   (0 Comments)
Posted by: Renee Olson
Share |
My time at CASSS has been such an important part of my life and career.
-
Brian K. Nunnally
I ... still love the vibe of the meetings and the focus on solving real issues with practical solutions.
- Cari Sänger-van de Griend
As the newest member of the Board of Directors, my goal is to build upon this strong legacy so that CASSS can continue to meet the needs of all its stakeholders including, ultimately, the needs of the patients we serve.
- Patrick Swann

CASSS – Sharing Science Solutions is pleased to announce Brian K. Nunnally and Cari Sänger-van de Griend Re-Elected and Patrick Swann Elected to CASSS Board of Directors.  They will join the twelve-member board responsible for governance and strategic direction of the association.  Brian, Cari and Patrick are all honored to be elected to the CASSS Board of Directors.

“My time at CASSS has been such an important part of my life and career”, Brian reflected. “Despite being all those years ago, I still remember the joy I felt when I got involved with organizing my first meeting.  I get the same feeling today although I feel I am able to give so much more than I could back then.  We have a tremendous set of goals to deliver on in the next few years and I am happy to be able to contribute to our success.”

Cari said, “My first conscious contact with CASSS was at CE Pharm 2002. I loved the atmosphere of sharing and helping each other out in a scientific manner and with a focus on the patient. Over the years I got more and more involved in the organization and still love the vibe of the meetings and the focus on solving real issues with practical solutions. I believe in globally sharing science solutions and in bridging between industry, academia, regulators and vendors. CASSS and I share the dream of connecting the right people to solve the analytical and regulatory challenges with the patient in focus.”

“During my over 20 years of attending CASSS conferences, I have found a consistent spirit of collaboration and innovation”, Patrick recalled.  “’Sharing Science Solutions’ represents a commitment to industry, academic and regulatory professionals to help in our common efforts related to biopharmaceutical development.   As the newest member of the Board of Directors, my goal is to build upon this strong legacy so that CASSS can continue to meet the needs of all its stakeholders including, ultimately, the needs of the patients we serve.”

Nunnally is Global Head of Quality Control for Seqirus. He has a Ph. D in Chemistry from Duke University and a BS with Honors from South Carolina Honors College in Marine Science and Chemistry from University of South Carolina.

Nunnally has been active on multiple scientific organizing committees at CASSS including WCBP (since 2009) and CE Pharm (2002-2008).  His also involved as an Associate Director (since 2011) and Board of Directors (since 2017) which includes an active role on the Portfolio Committee (2011-2013), Finance Committee (since 2015) and Technology Committee (since 2017).

Sanger – van de Griend is CEO and Founder of Kantisto BV.  She has a Ph.D in Analytical Pharmaceutical Chemistry from Uppsala University and a MSc in BioPharmaceutical Sciences from Leiden University. 


Sanger – van de Griend has been active on multiple scientific organizing committees at CASSS including CE Pharm (2008-2016), AT Europe (since 2015) and Netherlands Area Biotech Discussion Group (since 2016).  She also involved as an Associate Director (since 2009) and Board of Directors (2015-2018) which includes an active role on the Academic Outreach Committee (2014-2019).   

Swann is Vice President at Amgen Inc.  He has a Ph.D in Pharmacology from University of Illinois at Chicago, MS in Veterinary Physiology and Pharmacology from Purdue University and a BS in Individual Studies – Neuroscience from University of Maryland.

Swann has been active on multiple scientific organizing committees at CASSS including WCBP (2007-2013) and CMC North America Strategy Forum (2012-2015).  He also involved as an Associate Director (since 2015).


more Calendar

9/14/2020 » 9/17/2020
Mass Spec 2020

9/28/2020 » 10/1/2020
CE Pharm 2020

Membership Software Powered by YourMembership  ::  Legal